| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/22/2011 | US20110230552 Use of dronedarone for the preparation of a medicament for the prevention of stroke or transient ischemic attack |
| 09/22/2011 | US20110230551 Withaferin a analogs and uses thereof |
| 09/22/2011 | US20110230550 Compounds, compositions and methods |
| 09/22/2011 | US20110230549 Pharmaceutical compositions for the treatment of pain |
| 09/22/2011 | US20110230547 Potential Prognostic Markers and Therapeutic Targets for Neurological Disorders |
| 09/22/2011 | US20110230546 dsRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTION |
| 09/22/2011 | US20110230545 Eml4-alk fusion gene |
| 09/22/2011 | US20110230544 Modulation of c-reactive protein expression |
| 09/22/2011 | US20110230543 Oligoribonucleotide inhibitors of nrf2 and methods of use thereof for treatment of cancer |
| 09/22/2011 | US20110230542 Compositions and Methods for Inhibiting Expression of the PCSK9 Gene |
| 09/22/2011 | US20110230541 Process for the preparation of rotigotine |
| 09/22/2011 | US20110230540 Manassatin compounds and methods of making and using the same |
| 09/22/2011 | US20110230539 Small Molecule Inhibitors of N-Terminus Activation of the Androgen Receptor |
| 09/22/2011 | US20110230538 Pharmaceutical for use in the treatment of ureterolithiasis |
| 09/22/2011 | US20110230536 Phenylpyrazole inhibitors of store operated calcium release |
| 09/22/2011 | US20110230535 Imidazolinylmethyl aryl sulfonamide |
| 09/22/2011 | US20110230534 Composition For Local Anesthesia |
| 09/22/2011 | US20110230533 Imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of use |
| 09/22/2011 | US20110230532 Nitrooxy cycloalkane derivatives |
| 09/22/2011 | US20110230531 Therapeutic compounds |
| 09/22/2011 | US20110230530 Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient |
| 09/22/2011 | US20110230529 Benzamide glucokinase activators |
| 09/22/2011 | US20110230528 Use of Epothilone D in Treating Tau-Associated Diseases Including Alzheimer's Disease |
| 09/22/2011 | US20110230527 Caspase inhibitors and uses thereof |
| 09/22/2011 | US20110230526 Thiazolyl Mglur5 Antagonists and Methods for Their Use |
| 09/22/2011 | US20110230525 Dual-acting antihypertensive agents |
| 09/22/2011 | US20110230524 Substituted 2-(5-hydroxy-2-methyl-1h-indole-3-yl)acetic acids and ethers thereof and the use of same to treat viral diseases |
| 09/22/2011 | US20110230523 Transcription factor modulating compounds and methods of use thereof |
| 09/22/2011 | US20110230521 Pyrazole Compounds As CCR1 Antagonists |
| 09/22/2011 | US20110230520 Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases |
| 09/22/2011 | US20110230519 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 09/22/2011 | US20110230518 Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis |
| 09/22/2011 | US20110230517 Calcium receptor modulating agents |
| 09/22/2011 | US20110230516 CCR1 Antagonists and Methods of Use Therefor |
| 09/22/2011 | US20110230515 Compounds and methods for treatment and prevention of diseases |
| 09/22/2011 | US20110230514 Morphinan Compounds |
| 09/22/2011 | US20110230513 Pharmaceutical compositions for treatment of parkinsons disease |
| 09/22/2011 | US20110230512 Pharmaceutical Composition |
| 09/22/2011 | US20110230511 Carboxamide bioisosteres of opiates |
| 09/22/2011 | US20110230510 Pharmaceutical formulations containing opioid agonist, opioid antagonist and gelling agent |
| 09/22/2011 | US20110230509 Methods of use for cyclopamine analogs |
| 09/22/2011 | US20110230508 Novel Forms of a Fused Pyrrolocarbazole Compound |
| 09/22/2011 | US20110230507 Piperidine GPCR Agonists |
| 09/22/2011 | US20110230506 Predictive marker for egfr inhibitor treatment |
| 09/22/2011 | US20110230505 Quinazoline inhibitors of bace 1 and methods of using |
| 09/22/2011 | US20110230504 ALLEVIATING DISORDERS WITH COMBINING AGENTS THAT INCREASE EPOXYGENATED FATTY ACIDS AND AGENTS THAT INCREASE cAMP |
| 09/22/2011 | US20110230503 6, 9-Disubstituted Purine Derivatives and Their Use as Cosmetics and Cosmetic Compositions |
| 09/22/2011 | US20110230502 Modulation of chemosensory receptors and ligands associated therewith |
| 09/22/2011 | US20110230501 Pharmaceutical compositions for the treatment of diabetes mellitus |
| 09/22/2011 | US20110230500 Inhibitors of Phosphoinositide Dependent Kinase 1 (PDK1) |
| 09/22/2011 | US20110230499 Hsp90 inhibitors for therapeutic treatment |
| 09/22/2011 | US20110230498 Biaryl carboxamides |
| 09/22/2011 | US20110230497 Biologically active amides |
| 09/22/2011 | US20110230496 Novel process for preparing highly pure levocetirizine and salts thereof |
| 09/22/2011 | US20110230495 1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds |
| 09/22/2011 | US20110230494 Heteroaryl compounds and uses thereof |
| 09/22/2011 | US20110230493 1-OXA-8-Azaspiro [4,5] Decabe-8-Carboxamide Compounds as FAAH Inhibitors |
| 09/22/2011 | US20110230492 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 09/22/2011 | US20110230491 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 09/22/2011 | US20110230490 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 09/22/2011 | US20110230489 s-TRIAZINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME |
| 09/22/2011 | US20110230488 Hybrid-ionone and curcumin molecules as anticancer agents |
| 09/22/2011 | US20110230487 Arylsulfonamide ccr3 antagonists |
| 09/22/2011 | US20110230486 Modulators Of HEC1 Activity And Methods Therefor |
| 09/22/2011 | US20110230485 6-phenyl-pyrimidin-4-yl-(phenylamine or phenoxy) derivatives useful as modulators of nicotinic acetylcholine receptors |
| 09/22/2011 | US20110230484 Pyrazolyl-pyrimidine derivatives and their use as potassium channel modulators |
| 09/22/2011 | US20110230483 Pyridine and Pyrazine derivative for the Treatment of CF |
| 09/22/2011 | US20110230482 Compounds modulating c-fms and/or c-kit activity |
| 09/22/2011 | US20110230481 Derivatives of tetrabromobenzimidazole, a process for the preparation thereof, a pharmaceutical composition comprising the same, a method of using the same, a method for modulating or regulating serine/threonine kinases, and serine/threonine kinases modulating agent |
| 09/22/2011 | US20110230480 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders |
| 09/22/2011 | US20110230479 Neurotrophin mimetics and uses thereof |
| 09/22/2011 | US20110230477 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders |
| 09/22/2011 | US20110230476 Pi3 kinase inhibitors and uses thereof |
| 09/22/2011 | US20110230474 Topical antimicrobial compositions and methods of using same |
| 09/22/2011 | US20110230473 Methods and Compositions for Treating Status Epilepticus and Seizures Causing Status Epilepticus |
| 09/22/2011 | US20110230472 Ring-fused azole derivative having pi3k-inhibiting activity |
| 09/22/2011 | US20110230471 Benzonaphtyridine compounds as inhibitors of autotaxin |
| 09/22/2011 | US20110230470 Substituted pyrazolo[4,3-c]pyridine derivatives active as kinase inhibitors |
| 09/22/2011 | US20110230469 Method to Determine the Risk for Side Effects of an SSRI Treatment in a Person |
| 09/22/2011 | US20110230468 Fused heterocyclic compounds and uses thereof |
| 09/22/2011 | US20110230467 4,6-diaminonicotinamide compound |
| 09/22/2011 | US20110230466 Association of a sinus node if current inhibitor and calcium inhibitor and pharmaceutical compositions containing it |
| 09/22/2011 | US20110230465 Viral polymerase inhibitors |
| 09/22/2011 | US20110230464 Purine derivatives useful as p13 kinase inhibitors |
| 09/22/2011 | US20110230463 2h-chromene compound and derivative thereof |
| 09/22/2011 | US20110230462 Pyrrolopyrazine Kinase Inhibitors |
| 09/22/2011 | US20110230461 2,3-dihydro-1h-inden-1-yl-2,7-diazaspiro[3.5] nonane derivatives |
| 09/22/2011 | US20110230460 Thienotriazolodiazepine derivatives active on apo a |
| 09/22/2011 | US20110230459 Lactam acetamides as calcium channel blockers |
| 09/22/2011 | US20110230458 Phenyl-heteroaryl derivatives and methods of use thereof |
| 09/22/2011 | US20110230457 Substituted Isoquinolinones and Quinazolinones |
| 09/22/2011 | US20110230456 Nitridoosmium(VI) Complexes for Treatment of Cancer |
| 09/22/2011 | US20110230455 Aqueous-based pharmaceutical composition |
| 09/22/2011 | US20110230454 (aza)indole derivative and use thereof for medical purposes |
| 09/22/2011 | US20110230453 Use of Female Mammal's Urine for Determination of Fetal Gender Related Characteristics |
| 09/22/2011 | US20110230452 Compounds and methods for the treatment of pain and other diseases |
| 09/22/2011 | US20110230451 Identification and use of compounds that affect the fidelity of eukaryotic translation initiation codon selection |
| 09/22/2011 | US20110230450 Platelet-activating factor (paf) analogs and uses thereof |
| 09/22/2011 | US20110230448 Treatment and/or Prevention of Non-Viral Epithelial Damage |
| 09/22/2011 | US20110230447 Osteogenesis promoter comprising [4-(methylthio)phenylthio]methanebisphosphonic acid or pharmaceutically acceptable salt thereof as active ingredient |